Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS
Li Zhou(Harbin Institute of Technology), Amit Verma(M.J.P. Rohilkhand University)
Cited by 178
Related Papers
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
|JAMA Oncology|2021|185
Reduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I Kinase
|Cancer Research|2010|132
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia
|Nature Medicine|2015|128
Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways
|World Journal of Gastroenterology|2023|7